•
The round was led by Google Ventures, sources have told Forbes. Read more: UK AI video start-up Synthesia reportedly raises $200m at $4bn valuation
•
If you have an upcoming job interview in the cybersecurity space, here are a few top tips to ensure you are prepared. Read more: Top tips to prepare for a cybersecurity job interview
•
Huawei’s senior solutions director for energy storage said that Europe has a lot to learn from China about sustainability solutions. Read more: Huawei flaunts latest enterprise solutions at Dublin roadshow
•
A new report highlights the barriers part-time employees face and how challenges can be overcome. Read more: Do flexible workspaces encourage more engagement?
•
As the world experiences the second major cloud disruption in the space of a week, many are calling for an increased focus on digital sovereignty. Read more: What happened with the Microsoft Azure outage?
•
The chipmaker has firmly placed itself at the centre of the global AI boom. Read more: Nvidia makes history as first company to reach $5trn market value
•
Claroty’s Nick Haan discusses his organisation’s latest report on the cybersecurity challenges facing the manufacturing sector. Read more: Recent cyberattacks on manufacturing highlight need for smarter security

•
Fast-growing legal AI platform Legora today (30 October) announced the completion of a Series C round of $150m at a $1.8bn valuation, led by Bessemer Venture Partners, with significant investment from existing investors ICONIQ, General Catalyst, Redpoint Ventures, Benchmark, and Y Combinator. This raise sees Legora join the unicorn club – in its $80m…
•
The project hopes to enable a new generation of intelligent, energy-aware networks with the capacity to learn and adapt in real time. Read more: Trinity and Adapt to lead new AI mobile and wireless integration project
•
In a major private equity buy out deal, life science giant Thermo Fisher Scientific will pay up to $9.4bn cash to acquire drug trial data software firm Clario. Read more: Thermo Fisher acquires drug trial software firm Clario for up to $9.4bn